Loading lessons…
Loading lessons…
Curated lessons across 8 learning paths — from first concepts to trial summaries and practical protocols. Pick your level, follow the curriculum, and build real understanding.
Where are you starting?
Choose a learning path below or search the library. Progress saves in your browser.
Pick a track — progress rings update as you complete lessons.
32 lessons
6mDaily NAD+ supplementation can plateau due to NAMPT downregulation. Here's how to cycle NMN and NR for sustained results.
8mMOTS-C may help metabolic signaling in human cells, but the same signal could come with a repair cost. That matters for anyone reading the longevity hype.
8mMOTS-c is not just a mitochondrial story. In human cells, the same signal that turns on metabolism may also dampen repair, which makes context matter.
8mMOTS-c is not just a mitochondrial story. In human cells, the same signal that turns on metabolism may also dampen repair, which makes context matter.
9mMOTS-C sits at the intersection of mitochondrial signaling, glucose control, and recovery biology. Here is what the current research can actually support.
8mNew MOTS-C data points to something more specific than a generic metabolism story: better muscle mitochondrial efficiency. Here's what that means in practice.
8mMOTS-c is showing up in cardiac stress research. A new rat-heart study points toward mitochondrial bioenergetics, mtDNA integrity, and post-ischemic recovery.
8mMOTS-c is moving beyond generic energy claims. New research points toward mitochondrial stress response, lung inflammation, and cardiac reperfusion biology.
8mMOTS-c is being studied beyond energy and metabolism. New research points toward tissue-stress biology, lysosomal stability, and cell survival under ischemic pressure.
8mMOTS-c is moving beyond the generic energy peptide conversation. New 2026 research connects mitochondrial-derived peptides with atrial fibrosis, inflammation, and heart rhythm biology.
8mA new MOTS-c pilot study adds a vascular-health signal to the mitochondrial peptide conversation, but it should be read as biomarker research, not a protocol claim.
8mMOTS-c is one of the most interesting mitochondrial peptides in 2026 because the question is finally shifting from mechanism to human outcomes.
7mMOTS-c is a peptide encoded in your mitochondrial DNA that declines with age and mimics exercise benefits in animal studies. NAD+ has actual human clinical data. Here's what 2026 research shows about why these two molecules may work together — and what's still missing.
9mSLU-PP-332 is a small-molecule ERRα agonist with remarkable endurance, fat oxidation, and mitochondrial benefits. Here's the complete guide to what it does, who it's for, and how to use it.
5mLearn the proper technique for reconstituting NAD+ vials, understanding concentration calculations, and building an effective dosing protocol for your research needs.
7mMOTS-C has a real adjustment period. Here's why weeks 1-2 can feel rough, when the energy kick in, and how to maximize the transition.
8mMOTS-C timing affects AMPK activation and metabolic benefits. Learn whether to take it fasted, how long to wait before eating, and how to optimize timing for AM or PM training schedules.
8mThe MOTS-C dosing debate is real: 0.5-1mg daily vs 5mg 2-3x weekly. Both protocols have their advocates. Here's what the research says, why context matters, and how to choose the right approach for your situation.
9mAlready on Reta and ready to add compounds? Here's how to stack Tesamorelin and MOTS-C with Retatrutide for maximum fat loss and recomp.
9mRunning Retatrutide and wondering what to add? This guide breaks down how MOTS-C, SS-31, AOD-9604, and SLU-PP-332 layer onto a GLP-1 protocol — and why they're not redundant.
9mMOTS-C activates AMPK through mitochondrial signaling. NAD+ feeds the cellular energy substrate. Together, they hit the same system from two different angles — and the results are additive.
10mMOTS-C activates AMPK and drives mitochondrial adaptation — but does daily use over months cause your body to stop responding? Here's what the research and user experience actually says about long-term MOTS-C protocols.
8mMOTS-C is mitochondria-encoded and activates AMPK through a pathway that's less prone to classic receptor downregulation. Here's how to structure long-term use for sustained results.
8mMost people who take NAD+ daily wonder whether they should cycle it. The answer isn't black and white — it depends on your dose, delivery method, and goals. Here's what the research and community experience actually suggest.
7mMOTS-C is one of the most studied mitochondrial peptides for metabolic health and longevity. This guide covers dosing ranges, frequency, timing, stacking options, and what to track on protocol.
9mMOTS-c — a peptide synthesized inside your own mitochondria — is now in Phase 2a human trials for prediabetes. Early data suggests it improves insulin sensitivity and metabolic flexibility without the side effects of pharmaceutical interventions.
8mSS-31 and MOTS-C target mitochondrial health from two different angles. Here's how to run them together, when to introduce each, and what to expect.
9mDiscovered inside mitochondrial DNA itself, MOTS-c is one of the most fascinating longevity peptides in modern science. It governs how your cells produce energy, fight fat accumulation, and age.
8mNAD+ and peptides like BPC-157, MOTS-C, and KLOW work through completely different pathways — which is exactly why they stack well. Here's how to combine them safely and effectively.
8mBoth MOTS-C and GHK-Cu are popular among serious lifters over 50 — but they work through completely different mechanisms. Here's how to choose, and why the best answer is often both.
9mMOTS-C is the first peptide found encoded in mitochondrial DNA. It activates AMPK, mimics exercise-induced metabolic adaptations, and may be one of the most powerful tools for metabolic optimization available.
10mMOTS-C activates mitochondrial function and metabolic pathways linked to longevity and improved physical performance.
Also available at /blog for legacy links.